Perros, P.; Hegedus, L.; Bartalena, L. et al.
Graves' orbitopathy as a rare disease in Europe: a European Group on Graves' Orbitopathy (EUGOGO) position statementORPHANET JOURNAL OF RARE DISEASES. Bd. 12. 2017
Dietz, Julia; Vermehren, Johannes; Susser, Simone et al.
HCV resistance-associated substitutions in patients with HCV genotype 4 and failure to DAA combination therapies and implications for a retreatmentHEPATOLOGY. Bd. 66. 2017 S. 572A-573A
Hammond, Edward R.; Friedel, Heiko; Garal-Pantaler, Elena et al.
Health Care Costs of Patients with Systemic Lupus Erythematosus (SLE) Versus Control Patients As a Function of Disease Severity: Analysis of the Betriebskrankenkassen German Sickness FundARTHRITIS & RHEUMATOLOGY. Bd. 69. 2017
Huber, Y.; Labenz, C.; Ganter, M. et al.
Health-related quality of life in patients with non-alcoholic fatty liver diseaseJOURNAL OF HEPATOLOGY. Bd. 66. H. 1. 2017 S. S597-S598
Gehrke, Nadine; Woerns, Marcus A.; Mann, Amrit et al.
Hepatic B cell leukemia-3 suppresses chemically-induced hepatocarcinogenesis in mice through altered MAPK and NF-kappa B activationONCOTARGET. Bd. 8. H. 34. 2017 S. 56095-56109
Nagel, Michael; Schwarting, Andreas; Straub, Beate K. et al.
Hepatic manifestation of a macrophage activation syndrome (MAS)ZEITSCHRIFT FUR GASTROENTEROLOGIE. Bd. 55. H. 5. 2017 S. 473-478
Sprinzl, K.; Steinhoff, S.; von Hatzfeldt, S. et al.
Hepatitis B patients under oral nucleos(t)ide treatment with intermittent kidney function assessment (The BONIKA-study) - a multicenter, prospective, observational trial (NCT-Nr. 02267473)JOURNAL OF HEPATOLOGY. Bd. 66. H. 1. 2017 S. S477-S477
Hoesel, Marianna; Quasdorff, Maria; Ringelhan, Marc et al.
Hepatitis B Virus Activates Signal Transducer and Activator of Transcription 3 Supporting Hepatocyte Survival and Virus ReplicationCELLULAR AND MOLECULAR GASTROENTEROLOGY AND HEPATOLOGY. Bd. 4. H. 3. 2017 S. 339-363
Czauderna, C.; Marquardt, J. U.; Galle, P. R. et al.
Hepatocellular carcinomaINTERNIST. Bd. 58. H. 5. 2017 S. 469-479
Gehrke, N.; Hoevelmeyer, N.; Waisman, A. et al.
Hepatocyte-specific deletion of type I interleukin-1 receptor (IL-1RI) attenuates D-GalN/LPS-induced acute liver injury in vivoJOURNAL OF HEPATOLOGY. Bd. 66. H. 1. 2017 S. S341-S341